We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Williams-Sonoma
WSM
$29.6B
| $21.2M | 0.05% |
577,848
+457,132
| +379% | +$15.9M |
|
377
Aptiv
APTV
$10.3B
| $21.1M | 0.05% |
+222,062
| New | +$20.3M |
|
378
Ericsson
ERIC
$33.3B
| $21.1M | 0.05% |
2,399,684
-4,239,695
| -64% | -$37.5M |
|
379
Ryder
R
$10.1B
| $21M | 0.05% |
387,353
+174,748
| +82% | +$9.09M |
|
380
Innoviva
INVA
$1.48B
| $21M | 0.05% |
1,482,684
+1,098,054
| +285% | +$13.5M |
|
381
Liberty Global Class C
LBTYK
$3.49B
| $20.9M | 0.05% |
958,927
+915,027
| +2,084% | +$20.6M |
|
382
Carlyle Secured Lending
CGBD
$758M
| $20.9M | 0.05% |
1,559,860
+427,189
| +38% | +$5.92M |
|
|
MOMO
383
Hello Group
MOMO
$866M
| $20.4M | 0.05% |
+609,471
| New | +$21.7M |
|
384
Factset
FDS
$10.2B
| $20.3M | 0.05% |
75,808
+2,601
| +4% | +$668K |
|
385
DaVita
DVA
$11.7B
| $20.3M | 0.05% |
+270,754
| New | +$18M |
|
386
DHT Holdings
DHT
$3.02B
| $20.3M | 0.05% |
2,452,560
+904,985
| +58% | +$6.71M |
|
|
ARCH
387
DELISTED
Arch Resources, Inc.
ARCH
| $20.2M | 0.05% |
281,170
+193,979
| +222% | +$14.9M |
|
|
DCH
388
Dauch Corp
DCH
$1.51B
| $20M | 0.05% |
1,859,178
+1,186,678
| +176% | +$11.3M |
|
|
MDP
389
DELISTED
Meredith Corporation
MDP
| $20M | 0.05% |
615,747
+185,346
| +43% | +$6.59M |
|
390
Idexx Laboratories
IDXX
$46.2B
| $20M | 0.05% |
+76,519
| New | +$20.2M |
|
391
Morningstar
MORN
$7.53B
| $19.8M | 0.05% |
131,132
-41,410
| -24% | -$6.36M |
|
392
Designer Brands
DBI
$333M
| $19.8M | 0.05% |
1,256,627
+58,652
| +5% | +$972K |
|
393
Liberty Latin America Class C
LILAK
$1.64B
| $19.7M | 0.05% |
1,182,811
+363,683
| +44% | +$5.63M |
|
394
International Bancshares
IBOC
$4.57B
| $19.6M | 0.05% |
456,078
-32,378
| -7% | -$1.34M |
|
395
HP
HPQ
$27.5B
| $19.6M | 0.05% |
954,552
+135,428
| +17% | +$2.57M |
|
396
Compañía de Minas Buenaventura
BVN
$8.67B
| $19.6M | 0.05% |
1,298,859
+907,002
| +231% | +$13.5M |
|
397
FormFactor
FORM
$9.17B
| $19.5M | 0.05% |
749,419
+669,299
| +835% | +$15.1M |
|
398
Popular Inc
BPOP
$11.1B
| $19.5M | 0.05% |
331,081
-351,886
| -52% | -$19.6M |
|
399
Strategy Inc
MSTR
$38.4B
| $19.4M | 0.05% |
1,360,800
+137,020
| +11% | +$2.04M |
|
400
RingCentral
RNG
$5.28B
| $19.4M | 0.05% |
114,907
-158,052
| -58% | -$26.1M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.